MaxCyte Inc
F:MYE0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of MaxCyte Inc (MYE0) under the Base Case is EUR per share. Compared with the current market price of 1.09 EUR, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years.
Create a free account · No card needed
Fundamental Analysis
What MaxCyte Does
MaxCyte sells cell-engineering tools that let scientists and drug makers move DNA, RNA, proteins, and other material into living cells. Its main product is an electroporation platform, along with disposable cartridges and related support services. The company’s customers are biotech and pharmaceutical firms, especially teams developing cell therapies and gene-edited medicines, as well as research labs that need reliable ways to modify cells.
- Headquarters
- United States of America US
- Employees
- 91
- IPO date
- Mar 29, 2016
Balance Sheet
Recent Events
Latest Earnings Call
MaxCyte agreed to acquire Akron Bio, broadening its cell-therapy manufacturing offering and expanding its commercial opportunity.
Open the earnings call- EPS
- −$0.05
- Expected
- −$0.08
- Surprise
- +37.5%
- Stock, day of the call
- −13.1%
MaxCyte insiders are selling less than usual
Past 12 months
Continue MYE0 Research
Decided on MaxCyte? Get an email when MYE0 reaches the price you’d buy at. Free with an account.
Other MaxCyte listings
What is the Intrinsic Value of one MYE0 stock?
The intrinsic value for MaxCyte Inc (MYE0) under the Base Case is EUR.
Is MYE0 stock undervalued or overvalued?
Compared with the current market price of 1.09 EUR, the stock appears .